Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO Guidelines Methodology Manual . ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines . Clinical Practice Guidelines and other guidance (“Guidance”) provided by ASCO is not a comprehensive or definitive guide to treatment options. It is intended for voluntary use by clinicians and should be used in conjunction with independent professional judgment. Guidance may not be applicable to all patients, interventions, diseases or stages of diseases. Guidance is based on review and…

• EL
  Eli Lilly and Company
• P
  Pfizer
• G
  GlaxoSmithKline
• KT
  Karyopharm Therapeutics
• RP
  Regeneron Pharmaceuticals
• NO
  NRG Oncology
• S
  Seagen
• E
  Eisai
• DS
  Daiichi Sankyo Europe